Drug Induced Osteonecrosis of the Jaws (DIONJ)
Drug Induced Osteonecrosis of the Jaws is bone exposure or infection of the jaw resulting from a side effect of one of several drugs. The definition is exposed bone, in a patient who has not had head or neck radiation or any metastatic disease, in which the exposure fails to heal over a period lasting 8 weeks.
Drug Induced Osteonecrosis of the Jaw symptoms
Patients with DIONJ can have symptoms such as pain, swelling, fistulae, ulcerated soft tissue, and pathological fractures.
What is Drug Induced Osteonecrosis of the Jaws or DIONJ?
DIONJ results in “dead bone” and is a result of taking one of several medications. It is exposed jaw bone that is often infected and is the result of poor wound healing. It is on the rise as the number of individuals taking bisphosphontes, or antiresorptive drugs, continues to rise. Although the chance of getting DIONJ is small, 0-.04%-.1% of oral bisphosphonate users and 2-10% (or .8-20%) of IV bisphosphonate users, the number of individuals taking these medications is huge. Patients that receive a combination of bisphosphonates and antiangiogenics have a 16% of getting DIONJ.
Since a tooth extraction is the trigger for most cases of DIONJ, dentists are paying close attention to individuals taking these drugs. A list of these drugs can be found on my oral surgery medical history form. Non-nitrogen containing bisphosphonates do no trigger DIONJ; drugs such as Bonefos (clodronate) and Didronel (etidronate) and other first generation bisphosphonates.
Why are these drugs so popular?
- 1 in 2 women will have a osteoporosis related fracture and 1 in 8 males
- 10 million Americans have osteoporosis
- 30% of hip fractures require long-term nursing care
- 20-30% of hip fractures result in death within a year
Bisphosphonates minimize, prevent, and treat osteoporosis and a list of other ailments including Paget’s disease, multiple myeloma, hypercalcemia, and metastatic breast cancer and prostate cancer.
Risk factors for Drug Induced Osteonecrosis of the Jaws
- Oral drug for >2 years
- IV drug HIGH RISK!!!
- Invasive procedure (complicated extraction)
- Denture wearer
- Older than 65
- Periodontal or gum disease
- Corticosteroid, immune suppressive drug use
- Systemic diseases such as diabetes and carcinomatosis
- Smoking, excessive alcohol, obesity
- See a dentist prior to beginning these medications and have teeth extracted that are potentially going to need extraction.
- Maintain a strong regimen of home oral health care, brushing and flossing.
- Visit your dentist at least twice a year for your regular cleanings and examinations.
- Avoid having a tooth extraction, in other words spend the extra money to save your teeth.
- Make sure your partial and or denture is fitting properly and most importantly be sure the appliance is not rubbing excessively in any spot(s).
Signs the patient is at high risk of DIONJ
How can a dentist treat a tooth that needs extraction in order to avoid DIONJ?
Dr. Reznick shares his technique in a video that shows a way to help avoid an extraction. The Association of Dental Implantology recommends CHX topically and antibiotics systemically if taking out a tooth. I have a comment on the comments section that has several studies supporting his technique.
The AAOMS recommends a 2 month drug holiday for anyone taking BPs for over 4 years.
If teeth or pieces of a tooth need to be extracted simply have a ortho rubber band placed on tooth and it will be slowly self-extracted (this may have risks also unsure) or have it slowly removed with orthodontics by pulling it out slowly with braces Forced eruption as an alternative to tooth extraction in long-term use of oral bisphosphonates JADA Dec 12 Smidt
Drug Induced Osteonecrosis of the Jaw treatment options for patients
- Long term local antimicrobials or systemic antimicrobials
- Cessation of causative medications
- Hyperbaric oxygen therapy
- Laser therapy
- Teriparatide, ozone, pertoxifylline, tocopherol
- Conservative and aggressive surgical treatment
According to a meta analysis by El-Rabbany JADA 2017 surgical therapy is better than non-surgical and mylohyoid flaps are better than mucoperiosteal flaps. The rest there is not enough data to support or aren’t important.
Antiresorptive drug associated osteonecrosis of the jaw (ARONJ)
Antiresorptive drug associated osteonecrosis of the jaw (ARONJ) and osteonecrosis of the jaw are both the same disease process as Drug Induced Osteonecrosis of the Jaws. ARONJ and DIONJ are the same, it’s just that the first term is older.
Medication-related osteonecrosis of the jaw (MRONJ)
Medication-related osteonecrosis of the jaw or MRONJ is yet another term for DIONJ.
Systemic review of medication related osteonecrosis of the jaw and dental implant failures
Marx presentation on surgical management of DIONJ.
Marx presentation on Drug Induced ONJ Definition and Stages.
Great pdf presentation.